- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩4.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩400,500.00
7D
0.6%
1Y
-42.8%
Samsung BiologicsLtd
Market Cap: ₩72.8t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,556,000.00
7D
0.5%
1Y
-1.7%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,850.00
7D
1.4%
1Y
22.0%
JW Shinyak
Market Cap: ₩128.2b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,050.00
7D
-2.4%
1Y
43.9%
JW Holdings
Market Cap: ₩281.6b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,005.00
7D
-3.1%
1Y
19.9%
SK Biopharmaceuticals
Market Cap: ₩6.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩83,800.00
7D
-4.0%
1Y
-15.3%